XML 119 R106.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
SEGMENTED INFORMATION (Schedule of operation segments information) (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]        
Net Sales $ 18,031 $ 19,319 $ 76,071 $ 33,401
Gross Profit 3,854 5,346 17,738 13,251
Net Loss from Continuing Operations (3,374) (3,186) (46,669) (46,703)
Assets 24,274   23,626 80,987
Commercial & Wholesale [Member]        
Segment Reporting Information [Line Items]        
Net Sales 11,342 7,958 38,262 87
Gross Profit     2,218 (39)
Net Loss from Continuing Operations (236) 140 (8,763) (109)
Assets 10,473   9,096 22,225
House of Brands [Member]        
Segment Reporting Information [Line Items]        
Net Sales 8,020 13,765 44,602 39,419
Gross Profit     15,520 13,290
Net Loss from Continuing Operations (967) (354) (31,399) (29,594)
Assets 11,377   11,608 48,950
Pharmaceuticals [Member]        
Segment Reporting Information [Line Items]        
Net Sales     0 0
Gross Profit     0 0
Net Loss from Continuing Operations     (81) 0
Assets     0 3,313
Corp & Eliminations [Member]        
Segment Reporting Information [Line Items]        
Net Sales (1,331) (2,404) (6,793) (6,105)
Gross Profit     0 0
Net Loss from Continuing Operations (2,171) $ (2,972) (6,426) (17,000)
Assets $ 2,424   $ 2,922 $ 6,499